Burgen A S, Hiley C R, Young J M
Br J Pharmacol. 1974 Jun;51(2):279-85. doi: 10.1111/j.1476-5381.1974.tb09658.x.
1 The reaction of tritiated propylbenzilylcholine mustard ([(3)H]-PrBCM; N-2'-chloroethyl-N-[2'',3''-(3)H(2)] -propyl-2-aminoethylbenzilate) with homogenates of mammalian brain has been studied.2 The uptake can be divided into an atropine-sensitive component of fixed capacity (380 pmol/g protein in the rat) and an atropine-insensitive part.3 The atropine-sensitive portion is identified as muscarinic receptor by its insensitivity to nicotinic antagonists and anticholinesterases and its sensitivity to a range of muscarinic antagonists.4 The uptake of [(3)H]-PrBCM is also inhibited by muscarinic agonists and there is reasonable quantitative agreement between the affinities of agonists estimated in this way and in intact tissues by physiological responses.5 The fraction of [(3)H]-PrBCM uptake inhibited by muscarinic antagonists and agonists is the same.6 The amount of receptor found in six mammalian species was inversely related to the size of the brain, but the rates of alkylation and the sensitivity to atropine were not dissimilar.
研究了氚标记的丙基苯甲酰胆碱氮芥([(3)H]-PrBCM;N-2'-氯乙基-N-[2'',3''-(3)H(2)]-丙基-2-氨基乙基苯甲酸酯)与哺乳动物脑匀浆的反应。
摄取可分为固定容量的阿托品敏感成分(大鼠中为380 pmol/g蛋白质)和阿托品不敏感部分。
阿托品敏感部分因其对烟碱拮抗剂和抗胆碱酯酶不敏感以及对一系列毒蕈碱拮抗剂敏感而被鉴定为毒蕈碱受体。
[(3)H]-PrBCM的摄取也受到毒蕈碱激动剂的抑制,通过这种方式估计的激动剂亲和力与完整组织中通过生理反应估计的激动剂亲和力之间存在合理的定量一致性。
毒蕈碱拮抗剂和激动剂抑制的[(3)H]-PrBCM摄取分数相同。
在六种哺乳动物物种中发现的受体数量与脑的大小呈负相关,但烷基化速率和对阿托品的敏感性并无差异。